RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RINALDI G
Collezione AOU Città della Salute di Torino

Items : 5

Predictors of In-Hospital Mortality in Older Inpatients with Suspected Infection. in Journal of the American Medical Directors Association / J Am Med Dir Assoc. 2023 Dec;24(12):1868-1873. doi: 10.1016/j.jamda.2023.06.012. Epub 2023 Jul 21.

2023
AO Cuneo
AOU Città della Salute di Torino

Fenoglio LM; Bo M; Marabotto M; Isaia G; Raspo S; Bracco C; Brambati T; De Vito D; Ronco G; Rinaldi G; Presta R; Brunetti E;

Comparison of Diagnostic Accuracies of qSOFA, NEWS, and MEWS to Identify Sepsis in Older Inpatients With Suspected Infection. in Journal of the American Medical Directors Association / J Am Med Dir Assoc. 2022 May;23(5):865-871.e2. doi: 10.1016/j.jamda.2021.09.005. Epub 2021 Oct 5.

2022
AOU Città della Salute di Torino

Ronco G; De Vito D; Brambati T; Rinaldi G; Isaia G; Brunetti E; Bo M;

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 28;11(6):979. doi: 10.3390/diagnostics11060979.

2021
AOU Città della Salute di Torino

Corino VDA; Bologna M; Calareso G; Licitra L; Ghi M; Rinaldi G; Caponigro F; Morelli F; Airoldi M; Allegrini G; Cassano A; Ferrari D; Mirabile A; Tosoni A; Galizia D; Merlano M; Sponghini A; Moretti G; Mainardi L; Bossi P;

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Sep;118:35-40. doi: 10.1016/j.ejca.2019.05.031. Epub 2019 Jul 9.

2019
AOU Città della Salute di Torino

Locati LD; Piovesan A; Durante C; Bregni M; Castagna MG; Zovato S; Giusti M; Ibrahim T; Puxeddu E; Fedele G; Pellegriti G; Rinaldi G; Giuffrida D; Verderame F; Bertolini F; Bergamini C; Nervo A; Grani G; Rizzati S; Morelli S; Puliafito I; Elisei R;

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

2017
AOU Città della Salute di Torino

Bossi P; Miceli R; Locati LD; Ferrari D; Vecchio S; Moretti G; Denaro N; Caponigro F; Airoldi M; Moro C; Vaccher E; Sponghini A; Caldara A; Rinaldi G; Ferrau F; Nolè F; Lo Vullo S; Tettamanzi F; Hollander L; Licitra L;